Search research articles
Contact Us
Filters
Showing results (101-110 of 119) with videos related to
Page
of 12
Sort By:
Journal of Geriatric Oncology
|
February 15, 2026
Real-world management and clinical outcomes of first line treatment of advanced renal cell carcinoma in older patients in Canada
Lauren Curry, Sunita Ghosh, Erica Arenovich, et al.
Cancers
|
February 13, 2025
Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC) in a Subpopulation of Elderly and Poor Performance Status Patients
Noa Shani Shrem, Ana-Alicia Beltran-Bless, Sunita Ghosh, et al.
Clinical Genitourinary Cancer
|
April 27, 2025
Optimal Timing of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Patients Considering Sarcomatoid Status: A Real-World Study
Ghady Bou-Nehme Sawaya, Simon Tanguay, Lori A Wood, et al.
European Urology Focus
|
November 5, 2021
Outcomes of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Real World Data from Canadian Centers
Alice Dragomir, Sara Nazha, Simon Tanguay, et al.
European Urology Oncology
|
December 14, 2023
Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic Therapies
Ghady Bou-Nehme Sawaya, Alice Dragomir, Lori A Wood, et al.
Clinical Genitourinary Cancer
|
March 6, 2026
Node Positive Resected Renal Cell Carcinoma Portends a Poor Prognosis: Results From the Canadian Kidney Cancer Collaboration
Jesse Tr Spooner, Christopher Bitcon, Wyatt MacNevin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 2, 2020
Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: Results from Canadian Kidney Cancer information system
Ryan Sun, Rodney H Breau, Ranjeeta Mallick, et al.
European Urology
|
May 5, 2020
Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma
Bimal Bhindi, Jeffrey Graham, J Connor Wells, et al.
The Oncologist
|
August 4, 2025
Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary Renal Cell Carcinoma
Manon De Vries-Brilland, Zineb Hamilou, Sunita Ghosh, et al.
Current Oncology (Toronto, Ont.)
|
August 28, 2024
Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database
Changsu Lawrence Park, Feras Ayman Moria, Sunita Ghosh, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 119) with videos related to
Sort By:
Page
of 12
Journal of Geriatric Oncology
|
February 15, 2026
Real-world management and clinical outcomes of first line treatment of advanced renal cell carcinoma in older patients in Canada
Lauren Curry, Sunita Ghosh, Erica Arenovich, et al.
Cancers
|
February 13, 2025
Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC) in a Subpopulation of Elderly and Poor Performance Status Patients
Noa Shani Shrem, Ana-Alicia Beltran-Bless, Sunita Ghosh, et al.
Clinical Genitourinary Cancer
|
April 27, 2025
Optimal Timing of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Patients Considering Sarcomatoid Status: A Real-World Study
Ghady Bou-Nehme Sawaya, Simon Tanguay, Lori A Wood, et al.
European Urology Focus
|
November 5, 2021
Outcomes of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Real World Data from Canadian Centers
Alice Dragomir, Sara Nazha, Simon Tanguay, et al.
European Urology Oncology
|
December 14, 2023
Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic Therapies
Ghady Bou-Nehme Sawaya, Alice Dragomir, Lori A Wood, et al.
Clinical Genitourinary Cancer
|
March 6, 2026
Node Positive Resected Renal Cell Carcinoma Portends a Poor Prognosis: Results From the Canadian Kidney Cancer Collaboration
Jesse Tr Spooner, Christopher Bitcon, Wyatt MacNevin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 2, 2020
Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: Results from Canadian Kidney Cancer information system
Ryan Sun, Rodney H Breau, Ranjeeta Mallick, et al.
European Urology
|
May 5, 2020
Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma
Bimal Bhindi, Jeffrey Graham, J Connor Wells, et al.
The Oncologist
|
August 4, 2025
Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary Renal Cell Carcinoma
Manon De Vries-Brilland, Zineb Hamilou, Sunita Ghosh, et al.
Current Oncology (Toronto, Ont.)
|
August 28, 2024
Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database
Changsu Lawrence Park, Feras Ayman Moria, Sunita Ghosh, et al.
Page
of 12